5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
@article{Dhurat20205AlphaRI, title={5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety}, author={R. Dhurat and A. Sharma and L. Rudnicka and G. Kroumpouzos and M. Kassir and H. Galadari and U. Wollina and T. Lotti and Masa Golubovic and I. Binic and S. Grabbe and M. Goldust}, journal={Dermatologic Therapy}, year={2020}, volume={33} }
Androgenetic alopecia (AGA) is a multifactorial disease that carries a significant psychological burden with it. Dihydrotestosterone, the main pathogenic androgen in AGA, is produced by conversion of testosterone, which is catalyzed by the 5‐alpha reductase (5‐AR) isoenzyme family. Finasteride and dutasteride are inhibitors of these enzymes. Finasteride, which is a single receptor 5‐alpha reductase inhibitor (5‐ARI), acts by blocking dihydrotestosterone (DHT). Dutasteride, a dual receptor DHT… CONTINUE READING
Topics from this paper
One Citation
Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
- Medicine
- International journal of nanomedicine
- 2021
References
SHOWING 1-10 OF 41 REFERENCES
Controversies in the treatment of androgenetic alopecia: The history of finasteride
- Medicine
- Dermatologic therapy
- 2019
- 6
Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- Medicine
- International journal of dermatology
- 2014
- 34
Multi‐therapies in androgenetic alopecia: review and clinical experiences
- Medicine
- Dermatologic therapy
- 2016
- 38
- PDF
Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti‐androgens
- Medicine
- Dermatologic therapy
- 2019
- 9
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 2004
- 385
- PDF
Can we halt male androgenetic alopecia progression without antiandrogenic drugs?
- Medicine
- Dermatologic therapy
- 2019
- 1
The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Medicine
- Korean journal of urology
- 2014
- 64
- PDF
Androgen metabolism as it affects hair growth in androgenetic alopecia.
- Medicine
- Dermatologic clinics
- 1996
- 108
The effects of chronic 5-alpha-reductase inhibitor (dutasteride) treatment on rat erectile function.
- Medicine
- The journal of sexual medicine
- 2011
- 44